|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/05 | (2006.01) |
| C12Q 1/68 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| C07D 233/54 | (2006.01) |
| (11) | Number of the document | 3119911 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15764560.7 |
| Date of filing the European patent application | 2015-03-23 | |
| (97) | Date of publication of the European application | 2017-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation | 2023-10-10 |
| (86) | Number | PCT/US2015/022058 |
| Date | 2015-03-23 |
| (87) | Number | WO 2015/143447 |
| Date | 2015-09-24 |
| (30) | Number | Date | Country code |
| 201461968595 P | 2014-03-21 | US |
| (72) |
TOLAR, Martin , US
HEY, John , US
KOCIS, Petr , US
YU, Jeremy , US
|
| (73) |
Alzheon, Inc. ,
111 Speen Street
Suite 306, Framingham, MA 01701,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Junginiai, skirti naudoti taikant Alzheimerio ligos gydymo būdą APOE4+/+ pacientams |
| COMPOUNDS FOR USE IN TREATING ALZHEIMER'S DISEASE IN APOE4+/+ PATIENTS |
| Payment date | Validity (years) | Amount | |
| 2026-02-20 | 12 | 289.00 EUR |
| 2027-03-23 |